
Doing the Touchy Math on Who Should Get a COVID Vaccine First
Mathematicians model pandemic scenarios by plugging thorny ethical and logistical issues into calculations

Doing the Touchy Math on Who Should Get a COVID Vaccine First
Mathematicians model pandemic scenarios by plugging thorny ethical and logistical issues into calculations

The Antibiotic Gamble
Paratek Pharmaceuticals made a life-saving drug and got it approved. So why is the company’s long-term survival still in question?


The COVID Cold Chain: How a Vaccine Will Get to You
A vaccine logistics expert explains how millions of frozen vials will be widely distributed

Your Tears Might Save Your Life Someday
They could ultimately be used to find diseases the way blood tests do now—but cheaper and more easily

For Billion-Dollar COVID Vaccines, Basic Government-Funded Science Laid the Groundwork
Much of the pioneering work on mRNA vaccines was done with government money, though drugmakers could walk away with big profits

COVID Vaccine Excitement Builds as Moderna Reports Positive Result
Preliminary data show that the immunization is 94 percent effective and seems to prevent severe infections

For COVID Drugs, Months of Frantic Development Lead to Few Outright Successes
There have been mixed results as researchers try to stop a disease they are still trying to understand

An Emerging Tool for COVID Times: The Portable MRI
Bedside imaging holds vast potential as a diagnostic tool, especially during the pandemic

Early COVID Vaccine Results Bode Well for an Approval This Year
The data are preliminary, however, and it is not yet clear whether the vaccine protects against severe disease

Digital Medicine Can Diagnose and Treat What Ails You
Therapeutic and diagnostic apps and bots are almost here

Microneedles Could Enable Painless Injections and Blood Draws
Fewer trips to medical labs make care more accessible

Virtual Patients Could Revolutionize Medicine
Replacing humans with digital simulations could make clinical trials faster and safer